MONITORING OF HAEMATOLOGIC, CYTOGENETIC AND MOLECULAR RESPONSES IN CHRONIC MYELOID LEUKEMIA PATIENTS ON TKI THERAPY

被引：0
|
作者：
Mahmood, Rafia [1 ]
Malik, Hamid Saeed [1 ,2 ]
Suhail, Maymoona [1 ,2 ]
机构：
[1] Armed Forces Inst Pathol, Rawalpindi, Pakistan
[2] Natl Univ Med Sci, Rawalpindi, Pakistan
来源：
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY | 2024年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：61 / 62
页数：2
相关论文
共 50 条
  • [31] Molecular cytogenetic study of derivative chromosome 9 deletion in chronic myeloid leukemia patients
    Ayda Bennour
    Ines Ouahchi
    Yosra Ben Youssef
    Monia Zaier
    Mohamed Adnéne Laatiri
    Imed Harrabi
    Balkis Meddeb
    Moez Elloumi
    Abderrahim Khelif
    Ali Saad
    Halima Sennana
    Medical Oncology, 2012, 29 : 1151 - 1160
  • [32] Factors predicting molecular and cytogenetic response in chronic myeloid leukemia patients treated with imatinib
    Roche-Lestienne, C
    Darré, S
    Laï, DL
    Facon, T
    Guilhot, J
    Preudhomme, C
    HAEMATOLOGICA, 2005, 90 (01) : 131 - 133
  • [33] Cardiovascular care of patients with chronic myeloid leukemia (CML) on tyrosine kinase inhibitor (TKI) therapy
    Barber, Mary C.
    Mauro, Michael J.
    Moslehi, Javid
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2017, : 110 - 114
  • [34] Molecular cytogenetic study of derivative chromosome 9 deletion in chronic myeloid leukemia patients
    Bennour, Ayda
    Ouahchi, Ines
    Ben Youssef, Yosra
    Zaier, Monia
    Laatiri, Mohamed Adnene
    Harrabi, Imed
    Meddeb, Balkis
    Elloumi, Moez
    Khelif, Abderrahim
    Saad, Ali
    Sennana, Halima
    MEDICAL ONCOLOGY, 2012, 29 (02) : 1151 - 1160
  • [35] Molecular cytogenetic characterization of Philadelphia-negative rearrangements in chronic myeloid leukemia patients
    Ayda Bennour
    Hatem Bellâaj
    Yosra Ben Youssef
    Moez Elloumi
    Abderrahim Khelif
    Ali Saad
    Halima Sennana
    Journal of Cancer Research and Clinical Oncology, 2011, 137 : 1329 - 1336
  • [36] Hematologic and Molecular Responses to Generic Imatinib in Patients With Chronic Myeloid Leukemia
    Razmkhah, Farnaz
    Razavi, Mohsen
    Zaker, Farhad
    Kazemi, Ahmad
    Negari, Shahin
    Rasighaemi, Parisa
    Kalantarmotamedi, Mojdeh
    Zarei, Mina
    Pazhakh, Vahid
    LABMEDICINE, 2010, 41 (09): : 547 - 550
  • [37] CYTOGENETIC AND MOLECULAR STUDIES IN PATIENTS WITH CHRONIC MYELOID-LEUKEMIA AND VARIANT PHILADELPHIA TRANSLOCATIONS
    ZACCARIA, A
    TESTONI, N
    TASSINARI, A
    CELSO, B
    RASSOOL, F
    SAGLIO, G
    GUERRASIO, A
    ROSTI, G
    TURA, S
    CANCER GENETICS AND CYTOGENETICS, 1989, 42 (02) : 191 - 201
  • [38] Evolution of therapy monitoring of chronic myeloid leukemia
    Kutsev, S., I
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2009, 54 (04): : 37 - 44
  • [39] Molecular monitoring of chronic myeloid leukemia patients by droplet digital PCR
    Moebius, S.
    Schaefer, V.
    Waldau, A.
    Ernst, P.
    Maier, J.
    Franke, G. -N.
    Lange, T.
    Hochhaus, A.
    Ernst, T.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 122 - 122
  • [40] New Tool for Monitoring Molecular Response in Patients With Chronic Myeloid Leukemia
    Badar, Talha
    Luthra, Rajyalakshmi
    Kantarjian, Hagop
    Jabbour, Elias
    Borthakur, Gautam
    Garcia-Manero, Guillermo
    Huang, Xuelin
    Singh, Rajesh
    Alvarez, Brittany
    Austermiller, Bradley
    Morrison, Tom B.
    Patel, Keyur P.
    Cortes, Jorge
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2019, 27 (01) : 33 - 39
12345